Concepts (123)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Poliovirus Vaccine, Oral | 2 | 2017 | 95 | 1.24 | Why? |
| Poliomyelitis | 2 | 2017 | 263 | 1.00 | Why? |
| Adenosylmethionine Decarboxylase | 1 | 2018 | 2 | 0.79 | Why? |
| Trypanosomiasis | 1 | 2018 | 2 | 0.79 | Why? |
| Trypanosoma brucei brucei | 1 | 2018 | 9 | 0.78 | Why? |
| Enzyme Activators | 1 | 2018 | 24 | 0.77 | Why? |
| S-Adenosylmethionine | 1 | 2018 | 137 | 0.72 | Why? |
| Product Surveillance, Postmarketing | 1 | 2020 | 189 | 0.72 | Why? |
| Gene Expression Regulation, Enzymologic | 1 | 2018 | 436 | 0.58 | Why? |
| Waste Management | 1 | 2017 | 240 | 0.49 | Why? |
| Rotavirus Vaccines | 2 | 2013 | 203 | 0.46 | Why? |
| Tennessee | 3 | 2021 | 243 | 0.31 | Why? |
| Public Health Surveillance | 2 | 2021 | 3129 | 0.28 | Why? |
| Systemic Inflammatory Response Syndrome | 5 | 2021 | 6653 | 0.26 | Why? |
| Observation | 1 | 2021 | 80 | 0.22 | Why? |
| United States | 17 | 2021 | 46150 | 0.18 | Why? |
| Diarrhea | 1 | 2011 | 2743 | 0.18 | Why? |
| Work | 1 | 2020 | 342 | 0.17 | Why? |
| Personnel, Hospital | 2 | 2020 | 2273 | 0.16 | Why? |
| Risk-Taking | 1 | 2021 | 508 | 0.16 | Why? |
| Protein Subunits | 1 | 2018 | 755 | 0.15 | Why? |
| Vaccination | 3 | 2021 | 19050 | 0.15 | Why? |
| Medical Waste Disposal | 1 | 2017 | 221 | 0.14 | Why? |
| Bias | 1 | 2020 | 1109 | 0.14 | Why? |
| Ambulatory Care Facilities | 3 | 2020 | 2063 | 0.14 | Why? |
| Antibodies, Viral | 5 | 2021 | 51949 | 0.14 | Why? |
| Telecommunications | 1 | 2020 | 551 | 0.14 | Why? |
| Hospitalization | 6 | 2021 | 54280 | 0.14 | Why? |
| Sterilization | 1 | 2017 | 294 | 0.14 | Why? |
| Drug Substitution | 1 | 2017 | 385 | 0.13 | Why? |
| Outpatients | 3 | 2021 | 3417 | 0.12 | Why? |
| Observational Studies as Topic | 1 | 2020 | 1887 | 0.12 | Why? |
| Seroepidemiologic Studies | 4 | 2021 | 10017 | 0.12 | Why? |
| Ventricular Dysfunction, Left | 1 | 2021 | 993 | 0.12 | Why? |
| Immunoglobulins, Intravenous | 2 | 2021 | 2705 | 0.12 | Why? |
| Mississippi | 2 | 2021 | 80 | 0.11 | Why? |
| Communicable Disease Control | 1 | 2021 | 29620 | 0.11 | Why? |
| Health Personnel | 2 | 2021 | 29646 | 0.11 | Why? |
| Disease Eradication | 1 | 2017 | 581 | 0.11 | Why? |
| Adolescent | 13 | 2021 | 86841 | 0.10 | Why? |
| Recovery of Function | 1 | 2020 | 2461 | 0.10 | Why? |
| Environmental Exposure | 1 | 2020 | 1558 | 0.10 | Why? |
| Odds Ratio | 1 | 2021 | 5861 | 0.09 | Why? |
| Rotavirus Infections | 1 | 2013 | 355 | 0.09 | Why? |
| Child, Preschool | 8 | 2021 | 36283 | 0.09 | Why? |
| Glucocorticoids | 2 | 2021 | 4431 | 0.09 | Why? |
| Community-Acquired Infections | 1 | 2020 | 2328 | 0.09 | Why? |
| Case-Control Studies | 3 | 2021 | 17671 | 0.08 | Why? |
| Humans | 29 | 2021 | 930598 | 0.08 | Why? |
| Symptom Assessment | 1 | 2020 | 4967 | 0.08 | Why? |
| Immunogenicity, Vaccine | 1 | 2020 | 4624 | 0.07 | Why? |
| Immunization, Passive | 1 | 2020 | 10067 | 0.07 | Why? |
| Inpatients | 1 | 2020 | 5161 | 0.07 | Why? |
| Population Surveillance | 1 | 2021 | 4967 | 0.07 | Why? |
| Ambulatory Care | 1 | 2020 | 4947 | 0.06 | Why? |
| Nervous System Diseases | 1 | 2021 | 4092 | 0.06 | Why? |
| Mexico | 1 | 2011 | 2787 | 0.06 | Why? |
| Vaccines | 1 | 2021 | 3692 | 0.06 | Why? |
| Immunization Programs | 2 | 2013 | 2006 | 0.06 | Why? |
| Immunomodulation | 2 | 2021 | 1472 | 0.06 | Why? |
| Male | 18 | 2021 | 367725 | 0.06 | Why? |
| Child | 8 | 2021 | 70012 | 0.06 | Why? |
| Infant | 4 | 2021 | 30274 | 0.05 | Why? |
| Adult | 11 | 2021 | 244371 | 0.05 | Why? |
| Female | 17 | 2021 | 380317 | 0.05 | Why? |
| Contact Tracing | 1 | 2020 | 8448 | 0.05 | Why? |
| Respiratory Tract Infections | 1 | 2021 | 6817 | 0.05 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.05 | Why? |
| Coronavirus Infections | 7 | 2020 | 253789 | 0.05 | Why? |
| Quality of Life | 1 | 2021 | 9820 | 0.05 | Why? |
| Risk Factors | 4 | 2021 | 71621 | 0.05 | Why? |
| Vaccines, Synthetic | 2 | 2021 | 3231 | 0.05 | Why? |
| Young Adult | 7 | 2021 | 93724 | 0.04 | Why? |
| Academic Medical Centers | 2 | 2020 | 3088 | 0.04 | Why? |
| Disease Transmission, Infectious | 1 | 2021 | 9044 | 0.04 | Why? |
| Delivery of Health Care | 2 | 2021 | 15909 | 0.04 | Why? |
| Influenza, Human | 1 | 2021 | 10779 | 0.04 | Why? |
| Logistic Models | 2 | 2021 | 9089 | 0.04 | Why? |
| Emergency Service, Hospital | 1 | 2020 | 14232 | 0.04 | Why? |
| Demography | 1 | 2021 | 1660 | 0.03 | Why? |
| Treatment Outcome | 4 | 2021 | 51732 | 0.03 | Why? |
| Intensive Care Units, Pediatric | 1 | 2021 | 1098 | 0.03 | Why? |
| Middle Aged | 9 | 2021 | 270681 | 0.03 | Why? |
| Patient Acuity | 1 | 2021 | 1755 | 0.03 | Why? |
| Shock | 1 | 2021 | 1868 | 0.03 | Why? |
| Global Health | 1 | 2017 | 13911 | 0.03 | Why? |
| Regression Analysis | 1 | 2021 | 2484 | 0.03 | Why? |
| Infectious Disease Transmission, Professional-to-Patient | 1 | 2020 | 1316 | 0.03 | Why? |
| Propensity Score | 1 | 2021 | 2690 | 0.03 | Why? |
| Health Facilities | 1 | 2021 | 1230 | 0.03 | Why? |
| Combined Modality Therapy | 1 | 2021 | 3395 | 0.03 | Why? |
| Vaccination Coverage | 1 | 2021 | 1249 | 0.03 | Why? |
| Age Distribution | 1 | 2021 | 3567 | 0.03 | Why? |
| Stroke Volume | 1 | 2021 | 2153 | 0.03 | Why? |
| Patient Care | 1 | 2021 | 1664 | 0.02 | Why? |
| Infant, Newborn | 1 | 2011 | 23105 | 0.02 | Why? |
| Mucocutaneous Lymph Node Syndrome | 1 | 2020 | 1645 | 0.02 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.02 | Why? |
| Asymptomatic Diseases | 1 | 2020 | 3444 | 0.02 | Why? |
| Pandemics | 8 | 2021 | 389249 | 0.02 | Why? |
| Time Factors | 2 | 2021 | 31397 | 0.02 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2021 | 7268 | 0.02 | Why? |
| Critical Care | 2 | 2021 | 14081 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2021 | 7220 | 0.02 | Why? |
| Incidence | 2 | 2021 | 25622 | 0.02 | Why? |
| Prospective Studies | 2 | 2021 | 43301 | 0.02 | Why? |
| Patient Discharge | 1 | 2021 | 5696 | 0.02 | Why? |
| Retrospective Studies | 3 | 2021 | 105322 | 0.02 | Why? |
| Socioeconomic Factors | 1 | 2020 | 8495 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2021 | 17020 | 0.01 | Why? |
| Length of Stay | 1 | 2020 | 11042 | 0.01 | Why? |
| Aged | 3 | 2021 | 215776 | 0.01 | Why? |
| Age Factors | 1 | 2021 | 21039 | 0.01 | Why? |
| Cross Infection | 1 | 2020 | 8675 | 0.01 | Why? |
| Inflammation | 1 | 2020 | 13255 | 0.01 | Why? |
| Biomarkers | 1 | 2021 | 23361 | 0.01 | Why? |
| Risk Assessment | 1 | 2021 | 25439 | 0.01 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2020 | 53120 | 0.01 | Why? |
| Prevalence | 1 | 2013 | 25773 | 0.01 | Why? |
Patel's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(123)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(259)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_